Last reviewed · How we verify
Use of insulin glargine once daily
Use of insulin glargine once daily is a Small molecule drug developed by Eastern Virginia Medical School. It is currently FDA-approved.
At a glance
| Generic name | Use of insulin glargine once daily |
|---|---|
| Sponsor | Eastern Virginia Medical School |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4) (PHASE3)
- Once-Daily vs Twice-Daily Insulin Glargine in Pregestational Diabetes Management (PHASE4)
- iGlarLixi vs IDegAsp in Chinese Participants After OAD(s) (PHASE3)
- A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before (PHASE3)
- Closed Loop From Onset in Type 1 Diabetes (NA)
- FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR) (PHASE4)
- Efficacy and Safety Of Different Regimens In Patients With Type 2 Diabetes Receiving Intensive Insulin Therapy (PHASE3)
- Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Use of insulin glargine once daily CI brief — competitive landscape report
- Use of insulin glargine once daily updates RSS · CI watch RSS
- Eastern Virginia Medical School portfolio CI
Frequently asked questions about Use of insulin glargine once daily
What is Use of insulin glargine once daily?
Use of insulin glargine once daily is a Small molecule drug developed by Eastern Virginia Medical School.
Who makes Use of insulin glargine once daily?
Use of insulin glargine once daily is developed and marketed by Eastern Virginia Medical School (see full Eastern Virginia Medical School pipeline at /company/eastern-virginia-medical-school).
What development phase is Use of insulin glargine once daily in?
Use of insulin glargine once daily is FDA-approved (marketed).